Obesity

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Close X
Other videos you might like

Recent Videos

Video

HFSA 24: The HuMAIN-HFpEF Trial

Ambarish Pandey,

Watch time: 4m 5s

Video

EASD 24: Prespecified Analysis from the SELECT Trial

Helen Colhoun,

Watch time: 5m 37s

Video

Glucagon-Containing Dual and Triple Agonists For Obesity and MASH

Scott Harris,

Watch time: 8m 36s

Video Series

Advancements in Obesity Management

Harold Bays, Lydia Alexander, Liesbeth van Rossum, et al

Video

ECO 24: Long-Term Weight Loss in the SELECT trial

Donna H Ryan,

Watch time: 11m 42s

Video

ECO 24: Increasing GLP1-RA Efficacy by Targeting Non-coding RNA

Riccardo Panella,

Watch time: 4m 50s